Related references
Note: Only part of the references are listed.Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Elina Khatoon et al.
SEMINARS IN CANCER BIOLOGY (2022)
Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss
Chang Ho Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity
Yingying Chen et al.
JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY (2021)
Mitochondrial integration and ovarian cancer chemotherapy resistance
Luyan Shen et al.
EXPERIMENTAL CELL RESEARCH (2021)
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei et al.
MOLECULES (2021)
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei et al.
PHARMACOLOGICAL RESEARCH (2021)
The Role of Nrf2 in Hearing Loss
Dafei Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies
Qing Tang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
The rediscovery of platinum-based cancer therapy
Sven Rottenberg et al.
NATURE REVIEWS CANCER (2021)
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study
Eva Clemens et al.
PHARMACOGENOMICS JOURNAL (2020)
Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers
Suman Mukhopadhyay et al.
CANCER RESEARCH (2020)
Towards the overcoming of anticancer drug resistance mediated by p53 mutations
Xin Cao et al.
DRUG RESISTANCE UPDATES (2020)
Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents
Neife Aparecida Guinaim dos Santos et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma
He Du et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity
Fabiola Paciello et al.
SCIENTIFIC REPORTS (2020)
Curcumin-A Viable Agent for Better Bladder Cancer Treatment
Jochen Rutz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer
Wen Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
Current Strategies to Combat Cisplatin-Induced Ototoxicity
Dehong Yu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study
Thorsten Langer et al.
EUROPEAN JOURNAL OF CANCER (2020)
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Rui Liu et al.
CELL DEATH & DISEASE (2020)
Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy
Ignacio A. Cortes Fuentes et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Danfeng Xue et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline
David R. Freyer et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways
Alessia Parascandolo et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Phytochemicals: Current strategy to sensitize cancer cells to cisplatin
Chao-Yue Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients
Wendy A. Teft et al.
ORAL ONCOLOGY (2019)
Targeting Glutamine Metabolism and Redox State for Leukemia Therapy
Mark A. Gregory et al.
CLINICAL CANCER RESEARCH (2019)
Targeting dysregulation of redox homeostasis in noise-induced hearing loss: Oxidative stress and ROS signaling
Anna Rita Fetoni et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity
K. Fernandez et al.
HEARING RESEARCH (2019)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
Luca Lignitto et al.
CELL (2019)
Exploiting Mitochondrial Vulnerabilities to Trigger Apoptosis Selectively in Cancer Cells
Christopher Nguyen et al.
CANCERS (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy
Mario Negrette-Guzman
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Shang-Hung Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
Youngjin Han et al.
ONCOGENE (2019)
Cisplatin-Induced Ototoxicity: Updates on Molecular Targets
Erica Gentilin et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Cisplatin Toxicology: The Role of Pro-inflammatory Cytokines and GABA Transporters in Cochlear Spiral Ganglion
Dongmei Gao et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
H-Ferritin Affects Cisplatin-Induced Cytotoxicity in Ovarian Cancer Cells through the Modulation of ROS
Alessandro Salatino et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
Eun-Kyung Kim et al.
ANTIOXIDANTS (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
Hormetic effects of curcumin: What is the evidence?
Nazanin Sadat Aghili Moghaddam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The Role of Nrf2 signaling in cancer stem cells: From stemness and self-renewal to tumorigenesis and chemoresistance
Houman Kahroba et al.
LIFE SCIENCES (2019)
p53 as a hub in cellular redox regulation and therapeutic target in cancer
Sofi E. Eriksson et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
The genetic vulnerability to cisplatin ototoxicity: a systematic review
Evangelia Tserga et al.
SCIENTIFIC REPORTS (2019)
Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells
Dauren Alimbetov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Glutathione in Ovarian Cancer: A Double-Edged Sword
Sofia C. Nunes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Molecular mechanisms of drug resistance in ovarian cancer
Leyla Norouzi-Barough et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss
Robert A. Hazlitt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies
Balaraman Kalyanaraman et al.
REDOX BIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Chemoresistance and the Self-Maintaining Tumor Microenvironment
Gulcen Yeldag et al.
CANCERS (2018)
Reactive Oxygen Species: A Key Constituent in Cancer Survival
Seema Kumari et al.
BIOMARKER INSIGHTS (2018)
Comprehensive Landscape of Nrf2 and p53 Pathway Activation Dynamics by Oxidative Stress and DNA Damage
Steven Hiemstra et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
Reversible p53 inhibition prevents cisplatinototoxicity without blocking chemotherapeutic efficacy
Nesrine Benkafadar et al.
EMBO MOLECULAR MEDICINE (2017)
Reactive oxygen species and cancer paradox: To promote or to suppress?
Sehamuddin Galadari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer
Jakob Skalleberg et al.
GYNECOLOGIC ONCOLOGY (2017)
ROS-modulated therapeutic approaches in cancer treatment
Muhammad Hassan Raza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis
Xianmin Wu et al.
NEUROPHARMACOLOGY (2017)
The Roles of ROS in Cancer Heterogeneity and Therapy
Paulo Luiz de Sa Junior et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity
Signe Thiesen et al.
PHARMACOGENETICS AND GENOMICS (2017)
Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin
Claudia Lanvers-Kaminsky et al.
PHARMACOGENOMICS (2017)
Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity
Ramin Rezaee et al.
PHARMACOLOGICAL RESEARCH (2017)
Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss
Gilda M. Kalinec et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
Sandeep Sheth et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Cisplatin is retained in the cochlea indefinitely following chemotherapy
Andrew M. Breglio et al.
NATURE COMMUNICATIONS (2017)
Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture
Yucel Aydin et al.
SCIENTIFIC REPORTS (2017)
Dietary polyphenols: Antioxidants or not?
Kevin D. Croft
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Audiological Monitoring in Children Treated with Platinum Chemotherapy
A. R. Fetoni et al.
AUDIOLOGY AND NEURO-OTOLOGY (2016)
Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
Xupeng Bai et al.
DRUG METABOLISM REVIEWS (2016)
Styrene enhances the noise induced oxidative stress in the cochlea and affects differently mechanosensory and supporting cells
A. R. Fetoni et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Pathophysiology of the cochlear intrastrial fluid-blood barrier (review)
Xiaorui Shi
HEARING RESEARCH (2016)
The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
Stephanie Anais Castaldo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
TNF and ROS Crosstal in Inflammation
Heiko Blaser et al.
TRENDS IN CELL BIOLOGY (2016)
The Dual Roles of NRF2 in Cancer
Silvia Menegon et al.
TRENDS IN MOLECULAR MEDICINE (2016)
ROS homeostasis and metabolism: a critical liaison for cancer therapy
Jongdoo Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
A Curcumin Derivative That Inhibits Vinyl Carbamate-Induced Lung Carcinogenesis via Activation of the Nrf2 Protective Response
Tao Shen et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
Dionysios V. Chartoumpekis et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling
A. R. Fetoni et al.
BRITISH JOURNAL OF CANCER (2015)
Reactive Oxygen Species in Cancer: A Dance with the Devil
Paul T. Schumacker
CANCER CELL (2015)
Roles of Nrf2 in cell proliferation and differentiation
Shohei Murakami et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Metabolic pathways promoting cancer cell survival and growth
Lindsey K. Boroughs et al.
NATURE CELL BIOLOGY (2015)
Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer
Shrikant Balasaheb Mali
ORAL ONCOLOGY (2015)
Human OCT2 variant c.808G > T confers protection effect against cisplatin-induced ototoxicity
Claudia Lanvers-Kaminsky et al.
PHARMACOGENOMICS (2015)
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
Takatoshi Karasawa et al.
TOXICOLOGY LETTERS (2015)
Curcumin and tumor immune-editing: resurrecting the immune system
Sayantan Bose et al.
CELL DIVISION (2015)
Genetic Polymorphisms Associated with Hearing Threshold Shift in Subjects during First Encounter with Occupational Impulse Noise
Yohann Grondin et al.
PLOS ONE (2015)
Hormesis: Decoding Two Sides of the Same Coin
Dipita Bhakta-Guha et al.
PHARMACEUTICALS (2015)
Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies
Angela Callejo et al.
TOXICS (2015)
Heme Oxygenase-1 As a Target for Drug Discovery
Roberto Motterlini et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Synergistic inhibition of cancer cell proliferation with a combination of δ-tocotrienol and ferulic acid
Takahiro Eitsuka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
S. Nag et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Natural compounds to overcome cancer chemoresistance: toxicological and clinical issues
Eleonora Turrini et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Ferulic acid: Pharmacological and toxicological aspects
Cesare Mancuso et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Regulation of Nrf2-an update
Suryakant K. Niture et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
The Mdm Network and Its Regulation of p53 Activities: A Rheostat of Cancer Risk
Christine M. Eischen et al.
HUMAN MUTATION (2014)
Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation
Antonio Cuadrado et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin
Nasma D. Eljack et al.
METALLOMICS (2014)
Curcuma Longa (Curcumin) Decreases In Vivo Cisplatin- Induced Ototoxicity Through Heme Oxygenase-1 Induction
Anna R. Fetoni et al.
OTOLOGY & NEUROTOLOGY (2014)
NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)
Luciana O. Almeida et al.
FEBS OPEN BIO (2014)
Oxidative stress and cancer: An overview
Venus Sosa et al.
AGEING RESEARCH REVIEWS (2013)
Molecular mechanisms of curcumin action: Gene expression
Shishir Shishodia
BIOFACTORS (2013)
Establishing cellular stress response profiles as biomarkers of homeodynamics, health and hormesis
Dino Demirovic et al.
EXPERIMENTAL GERONTOLOGY (2013)
Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance
Suryakant K. Niture et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
Melba C. Jaramillo et al.
GENES & DEVELOPMENT (2013)
Functional Mechanotransduction Is Required for Cisplatin-Induced Hair Cell Death in the Zebrafish Lateral Line
Andrew J. Thomas et al.
JOURNAL OF NEUROSCIENCE (2013)
Clinical Significance of Keap1 and Nrf2 in Oral Squamous Cell Carcinoma
Cong-Fa Huang et al.
PLOS ONE (2013)
Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
Rossella Marullo et al.
PLOS ONE (2013)
Understanding platinum-induced ototoxicity
Thorsten Langer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Lack of p53 Decreases Basal Oxidative Stress Levels in the Brain Through Upregulation of Thioredoxin-1, Biliverdin Reductase-A, Manganese Superoxide Dismutase, and Nuclear Factor Kappa-B
Eugenio Barone et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Does Nrf2 Contribute to p53-Mediated Control of Cell Survival and Death?
Weimin Chen et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Glutathione-S-Transferases As Determinants of Cell Survival and Death
Kenneth D. Tew et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update
Neife Aparecida Guinaim dos Santos et al.
ARCHIVES OF TOXICOLOGY (2012)
Celebrating 25 years of NF-κB research
Sankar Ghosh et al.
IMMUNOLOGICAL REVIEWS (2012)
Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis
Suryakant K. Niture et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer
Mette Sprauten et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
Aditi Gupta et al.
MOLECULAR CANCER (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Transcription factor Nrf2 maintains the basal expression of Mdm2: An implication of the regulation of p53 signaling by Nrf2
Aram You et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Curcumin induces stress response and hormetically modulates wound healing ability of human skin fibroblasts undergoing ageing in vitro
Dino Demirovic et al.
BIOGERONTOLOGY (2011)
Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species
Yeong-In Yang et al.
GYNECOLOGIC ONCOLOGY (2011)
Signal transduction by reactive oxygen species
Toren Finkel
JOURNAL OF CELL BIOLOGY (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
p53 Facilitates BH3-only BID nuclear export to induce apoptosis in the irrepairable DNA damage response
Gang Song et al.
MEDICAL HYPOTHESES (2011)
Functional Hair Cell Mechanotransducer Channels Are Required for Aminoglycoside Ototoxicity
Abdelrahman Alharazneh et al.
PLOS ONE (2011)
Pharmacogenomics of cisplatin-induced ototoxicity
Debashree Mukherjea et al.
PHARMACOGENOMICS (2011)
Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation
T. Kaur et al.
CELL DEATH & DISEASE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
Giuliano Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Cancer Chemoprevention Mechanisms Mediated Through the Keap1-Nrf2 Pathway
John D. Hayes et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Polyphenols and health: Update and perspectives
Helmut Sies
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Inhibiting NF-kappa B activation by small molecules as a therapeutic strategy
Subash C. Gupta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Cisplatin resistance: Preclinical findings and clinical implications
Beate Koeberle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
Stephen Y. Lai et al.
DRUG RESISTANCE UPDATES (2010)
IN VIVO PROTECTIVE EFFECT OF FERULIC ACID AGAINST NOISE-INDUCED HEARING LOSS IN THE GUINEA-PIG
A. R. Fetoni et al.
NEUROSCIENCE (2010)
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
Ajay Goel et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
p53 post-translational modification: deregulated in tumorigenesis
Chao Dai et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Role of Oxidative Stress in Stem, Cancer, and Cancer Stem Cells
Ahmed Abdal Dayem et al.
Cancers (2010)
Nrf2 Plays an Important Role in Coordinated Regulation of Phase II Drug Metabolism Enzymes and Phase III Drug Transporters
Guoxiang Shen et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
Nrf2:INrf2 (Keap1) signaling in oxidative stress
James W. Kaspar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
Colin J. D. Ross et al.
NATURE GENETICS (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies
Leonard P. Rybak et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Curcumin: Preventive and therapeutic properties in laboratory studies and clinical trials
Alexios S. Strimpakos et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Curcumin as Curecumin:: From kitchen to clinic
Ajay Goel et al.
BIOCHEMICAL PHARMACOLOGY (2008)
ROS and p53: A versatile partnership
Bin Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Curcumin and the cellular stress response in free radical-related diseases
Vittorio Calabrese et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Hormetic Dietary Phytochemicals
Tae Gen Son et al.
NEUROMOLECULAR MEDICINE (2008)
Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
P. Pinton et al.
ONCOGENE (2008)
Genetic variants associated with cisplatin-induced ototoxicity
Jan Oldenburg et al.
PHARMACOGENOMICS (2008)
Dual roles of Nrf2 in cancer
Alexandria Lau et al.
PHARMACOLOGICAL RESEARCH (2008)
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
L. Riedemann et al.
PHARMACOGENOMICS JOURNAL (2008)
Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors
Jan Oldenburg et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Increased expression of nuclear factor E2 P45-related factor 2 (NRF2) in head and neck squamous cell carcinomas
Donnie R. Stacy et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2006)
Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo
CF Dai et al.
HEARING RESEARCH (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Multiple molecular targets in cancer chemoprevention by curcumin
Rajesh L. Thangapazham et al.
AAPS JOURNAL (2006)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels
W Marcotti et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation
S Sano et al.
CANCER RESEARCH (2005)
Protective effects of α-tocopherol and tiopronin against cisplatin-induced ototoxicity
AR Fetoni et al.
ACTA OTO-LARYNGOLOGICA (2004)
Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling
S Aggarwal et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose
Y Li et al.
EUROPEAN JOURNAL OF CANCER (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig
J Wang et al.
NEUROPHARMACOLOGY (2003)
Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage
B Sergi et al.
HEARING RESEARCH (2003)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
FM1-43 dye behaves as a permeant blocker of the hair-cell mechanotransducer channel
JE Gale et al.
JOURNAL OF NEUROSCIENCE (2001)
Acute changes in cochlear potentials due to cisplatin
N Tsukasaki et al.
HEARING RESEARCH (2000)
Death signal-induced localization of p53 protein to mitochondria - A potential role in apoptotic signaling
ND Marchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies
T Huang et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2000)
Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea
SA Alam et al.
HEARING RESEARCH (2000)
Share Paper
